Ligand Pharmaceuticals Eulerpool Nyheder

Ligand Pharmaceuticals Eulerpool News

Ligand Pharmaceuticals Aktie Nyheder

Ligand Pharmaceuticals bliver overvåget af mange journalister og investorer over hele verden. De seneste Ligand Pharmaceuticals nyheder samler vi her.

• 6. september ·

  Yahoo
  Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
• 6. september ·

  Thefly.com
  Ligand, Travere Therapeutics receives full FDA approval for Filspari
• 6. september ·

  Seeking Alpha
  Travere gains on full FDA approval for kidney drug Filspari
• 27. august ·

  Yahoo
  Insider Sale: President & COO Matthew Korenberg Sells 18,858 Shares of Ligand ...
• 20. august ·

  Yahoo
  Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference
• 19. august ·

  Seeking Alpha
  Small-cap and mid-cap Health Care has room to rally - Roth MKM
• 16. august ·

  Benzinga
  Looking Into Ligand Pharmaceuticals's Recent Short Interest
• 15. august ·

  Yahoo
  Ligand Pharmaceuticals (NASDAQ:LGND) Shareholders Should Be Cautious Despite Solid Earnings
• 15. august ·

  Yahoo
  Private Capital's Strategic Moves Highlight Ligand Pharmaceuticals in Q2 2024
• 12. august ·

  Seeking Alpha
  Roth MKM says Small-Cap Value reaches key technical support, lists 14 "bullish" stocks